Lara Meisner, Chief Legal Officer at Bicara Therapeutics Inc. ($BCAX), made five open market sales of company shares over the past year, totaling about $1.87 million. Her most recent sale occurred on September 29, 2025. These transactions rank her 3,632nd among 11,678 insiders in our database by sale value, below the average of $8.6 million across 6.4 transactions per insider. She reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 54,563,864 | 9999.99% | 0.16% |
| Sept. 29, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Common Stock | 33807 | $9.24 | 33,807.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| Sept. 29, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | S | Common Stock | 33807 | $14.75 | 0.0000 | 16,805,524,000 | 100.00% | 0.00% |
| Sept. 29, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 33807 | $0.00 | 101,423.0000 | 16,805,524,000 | 25.00% | 0.00% |
| Sept. 15, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | S | Common Stock | 15829 | $11.49 | 0.0000 | 16,805,524,000 | 100.00% | 0.00% |
| Sept. 15, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 9744 | $0.00 | 87,699.0000 | 16,805,524,000 | 10.00% | 0.00% |
| Sept. 15, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 6085 | $0.00 | 54,769.0000 | 16,805,524,000 | 10.00% | 0.00% |
| Sept. 15, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Common Stock | 15829 | $5.45 | 15,829.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 16, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Common Stock | 15829 | $5.45 | 15,829.0000 | 16,805,524,000 | 9999.99% | 0.00% |
| June 16, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | S | Common Stock | 15829 | $10.43 | 0.0000 | 16,805,524,000 | 100.00% | 0.00% |
| June 16, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 6085 | $0.00 | 60,854.0000 | 16,805,524,000 | 9.09% | 0.00% |
| June 16, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 9744 | $0.00 | 97,443.0000 | 16,805,524,000 | 9.09% | 0.00% |
| March 14, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 30246 | $0.00 | 67,119.0000 | 16,805,524,000 | 31.06% | 0.00% |
| March 14, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Stock Option (Right to Buy) | 48720 | $0.00 | 107,187.0000 | 16,805,524,000 | 31.25% | 0.00% |
| March 14, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | S | Common Stock | 30620 | $13.24 | 0.0000 | 16,805,524,000 | 100.00% | 0.00% |
| March 14, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | S | Common Stock | 48526 | $12.69 | 30,620.0000 | 16,805,524,000 | 61.31% | 0.00% |
| March 14, 2025 | Bicara Therapeutics Inc. | $BCAX | Meisner Lara | Chief Legal Officer | M | Common Stock | 79146 | $5.45 | 79,145.0000 | 16,805,524,000 | 0.00% | 0.00% |